Suppr超能文献

鼻咽癌放疗后患者的第二原发性鳞状细胞癌——预测因素和预后因素

Second primary squamous cell carcinoma in patients with nasopharyngeal carcinoma after radiotherapy-Predictors and prognostic factors.

作者信息

Wang Xi, Li Yin, Gao Yunfei, Ouyang Dian, Guo Zhuming

机构信息

Department of Otolaryngology, Guangzhou University of Traditional Chinese Medicine First Affiliated Hospital, Guangzhou, 510405, Guangdong, People's Republic of China.

Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.

出版信息

Head Neck. 2018 Jul;40(7):1434-1442. doi: 10.1002/hed.25130. Epub 2018 Mar 9.

Abstract

BACKGROUND

We investigated risk and prognostic factors for second primary squamous cell carcinoma (SCC) in patients with nasopharyngeal carcinoma (NPC) after radiotherapy (RT).

METHODS

A total of 49 021 patients with NPC were treated at Sun Yat-Sen Cancer Center between January 1970 and December 2009. The incidence and management of second primary SCCs were analyzed.

RESULTS

A total of 142 patients (0.29%) developed second primary SCC, with 78.2% in the upper aerodigestive tract. Older age, smoking, and chemotherapy were associated with an increased rate of second primary SCC. The 3, 5, and 10-year overall survival (OS) rates for second primary SCC were 47.18%, 31.69%, and 11.97%, respectively. Advanced age, family history of cancer, and treatment modality were independent prognostic factors for survival.

CONCLUSION

Second primary tumors rarely develop in patients with NPC treated with RT, but when this occurs, second primary SCC comprises a majority of these. Intensity-modulated RT may shorten the latency to second primary SCC. Surgery as the first-line treatment may improve survival and prognosis.

摘要

背景

我们研究了鼻咽癌(NPC)患者放疗(RT)后发生第二原发性鳞状细胞癌(SCC)的风险及预后因素。

方法

1970年1月至2009年12月期间,共有49021例NPC患者在中山大学肿瘤防治中心接受治疗。分析了第二原发性SCC的发病率及治疗情况。

结果

共有142例患者(0.29%)发生第二原发性SCC,其中78.2%发生于上呼吸消化道。年龄较大、吸烟和化疗与第二原发性SCC的发生率增加有关。第二原发性SCC的3年、5年和10年总生存率(OS)分别为47.18%、31.69%和11.97%。高龄、癌症家族史和治疗方式是生存的独立预后因素。

结论

接受RT治疗的NPC患者很少发生第二原发性肿瘤,但一旦发生,第二原发性SCC占大多数。调强放疗可能会缩短第二原发性SCC的潜伏期。手术作为一线治疗可能会改善生存及预后。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验